Adding IL-12 to mRNA vaccines can lead to longer lasting protective effect and a potential approach for reducing the risk of ...

In a groundbreaking leap forward in the global fight against HIV, researchers at Melbourne’s world-renowned Doherty Institute ...

The quickly evolving development of biopharmaceuticals is impacting innovation in the industry overall.

“Despite nearly four decades of effort by the global research community, an effective vaccine to prevent HIV remains an ...

Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...

The acquisition boosts BioNTech’s mRNA design and manufacturing capabilities, accelerating development of next-gen cancer ...

Using CRISPR to correct the mutations behind polycystic kidney disease could counter some of the damage the condition causes ...

The BioNTech SE acquisition of CureVac N.V. brings together complementary technologies, as both are developing mRNA ...

Researchers in Australia use COVID-era mRNA technology to expose hidden HIV in white blood cells, offering hope for a future ...

A new kind of cancer treatment is emerging—one that turns the patient’s own body into a drug factory. Here's what you need to ...

The global pharmaceutical lipids market is valued at USD 5.4 billion in 2025, registering Y-o-Y growth of 5.1% attaining market value of USD 9.0 billion by 2035. The revenue generated by allergy ...

A major bottleneck in curing HIV (human immunodeficiency virus) is that the virus can hide in an inactive form within resting white blood cells, which play a crucial role in coordinating the immune ...